A multi-institutional review of outcomes of endometrial stromal sarcoma

Gynecologic Oncology

Volumn 105, Issue 3, 2007, Pages 630-634

  Leath III, Charles A ^a   Huh, Warner K ^a   Hyde Jr , Johnny ^b   Cohn, David E ^c   Resnick, Kimberly E ^c   Taylor, Nicholas P ^d   Powell, Matthew A ^d   Mutch, David G ^d   Bradley, William H ^e   Geller, Melissa A ^e   Argenta, Peter A ^e   Gold, Michael A ^b  

^a University of Alabama   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Endometrial stromal sarcoma; High grade endometrial stromal sarcoma; Low grade endometrial stromal sarcoma; Multi institutional study; Outcomes

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE DERIVATIVE;

ADULT; AGED; ARTICLE; CALCULATION; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ENDOMETRIUM SARCOMA; FEMALE; HORMONAL THERAPY; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; STUDENT T TEST; UTERINE CERVIX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; SURVIVAL RATE;

EID: 34248386886     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.01.031     Document Type: Article

References (30)

1. Echt G., Jepson J., Steel J., Langholz B., Luxton G., Hernandez W., et al. Treatment of uterine sarcomas. Cancer 66 1 (1990 (Jul 1)) 35-39
2. Norris H.J., and Taylor H.B. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19 6 (1966 (Jun)) 755-766
3. Gadducci A., Sartori E., Landoni F., Zola P., Maggino T., Urgesi A., et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol. Oncol. 63 2 (1996 (Nov)) 247-253
4. Chen S.S. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. Gynecol. Oncol. 32 2 (1989 (Feb)) 215-217
5. Goff B.A., Rice L.W., Fleischhacker D., Muntz H.G., Falkenberry S.S., Nikrui N., et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol. Oncol. 50 1 (1993 (Jul)) 105-109
6. Peters III W.A., Kumar N.B., Fleming W.P., and Morley G.W. Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet. Gynecol. 63 4 (1984 (Apr)) 550-556
7. Riopel J., Plante M., Renaud M.C., Roy M., and Tetu B. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol. Oncol. 96 2 (2005 (Feb)) 402-406
8. Piver M.S., Rutledge F.N., Copeland L., Webster K., Blumenson L., and Suh O. Uterine endolymphatic stromal myosis: a collaborative study. Obstet. Gynecol. 64 2 (1984 (Aug)) 173-178
9. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., and Lewis Jr. J.L. Treatment of endometrial stromal tumors. Gynecol. Oncol. 36 1 (1990 (Jan)) 60-65
10. Katz L., Merino M.J., Sakamoto H., and Schwartz P.E. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors. Gynecol. Oncol. 26 1 (1987 (Jan)) 87-97
11. Mansi J.L., Ramachandra S., Wiltshaw E., and Fisher C. Endometrial stromal sarcomas. Gynecol. Oncol. 36 1 (1990 (Jan)) 113-118
12. Leunen M., Breugelmans M., De Sutter P., Bourgain C., and Amy J.J. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol. Oncol. 95 3 (2004 (Dec)) 769-771
13. Scribner Jr. D.R., and Walker J.L. Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace. Gynecol. Oncol. 71 3 (1998 (Dec)) 458-460
14. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 8 Suppl (1987 (Oct 15)) 2035-2041
15. Oliva E., Clement P.B., and Young R.H. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv. Anat. Pathol. 7 5 (2000 (Sep)) 257-281
16. Bodner K., Bodner-Adler B., Obermair A., Windbichler G., Petru E., Mayerhofer S., et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol. Oncol. 81 2 (2001 (May)) 160-165
17. Geller M.A., Argenta P., Bradley W., Dusenbery K.E., Brooker D., Downs Jr. L.S., et al. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol. Oncol. 95 3 (2004 (Dec)) 632-636
18. Bristow R.E., Zahurak M.L., Alexander C.J., Zellars R.C., and Montz F.J. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer 13 5 (2003 (Sep-Oct)) 664-672
19. Bristow R.E., Zerbe M.J., Rosenshein N.B., Grumbine F.C., and Montz F.J. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol. Oncol. 78 2 (2000 (Aug)) 85-91
20. Chi D.S., and Barakat R.R. Surgical management of advanced or recurrent endometrial cancer. Surg. Clin. North Am. 81 4 (2001 (Aug)) 885-896
21. Gloor E., Schnyder P., Cikes M., Hofstetter J., Cordey R., Burnier F., et al. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 50 9 (1982 (Nov 1)) 1888-1893
22. Pellillo D. Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a long-acting synthetic progestin: a case report. Obstet. Gynecol. 31 1 (1968 (Jan)) 33-39
23. Hoovis M.L. Response of endometrial stromal sarcoma to cyclophosphamide. Am. J. Obstet. Gynecol. 108 7 (1970 (Dec 1)) 1117-1119
24. Muss H.B., Bundy B., DiSaia P.J., Homesley H.D., Fowler Jr. W.C., Creasman W., et al. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer 55 8 (1985 (Apr 15)) 1648-1653
25. Omura G.A., Major F.J., Blessing J.A., Sedlacek T.V., Thigpen J.T., Creasman W.T., et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52 4 (1983 (Aug 15)) 626-632
26. Sutton G., Blessing J.A., Park R., DiSaia P.J., and Rosenshein N. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet. Gynecol. 87 5 Pt 1 (1996 (May)) 747-750
27. Szlosarek P.W., Lofts F.J., Pettengell R., Carter P., Young M., and Harmer C. Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel. Anticancer Drugs 11 4 (2000 (Apr)) 275-278
28. Yamawaki T., Shimizu Y., and Hasumi K. Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin. Gynecol. Oncol. 64 2 (1997 (Feb)) 265-269
29. Leath III C.A., Straughn Jr. J.M., Conner M.G., Barnes III M.N., Alvarez R.D., Partridge E.E., et al. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series. J. Reprod. Med. 49 2 (2004 (Feb)) 71-75
30. Moinfar F., Gogg-Kamerer M., Sommersacher A., Regitnig P., Man Y.G., Zatloukal K., et al. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach. Am. J. Surg. Pathol. 29 4 (2005 (Apr)) 485-489